CSIR, Laxai initiate phase-II trials of Niclosamide drug for treating Covid-19
The Council of Scientific and Industrial Research (CSIR) in collaboration with Laxai Life Sciences began the phase-II clinical trials of anti-helminthic drug Niclosamide on Sunday for treating the coronavirus disease (Covid-19). According…